Archive | Atrial Fibrillation RSS feed for this section

Should Atrial Fibrillation Patients Take Oral Anticoagulants? (video)

A majority of atrial fibrillation patients who have not been treated oral anticoagulants (OAC) meet guideline indications for treatment. Untreated patients are at increased risk for adverse outcomes. In this video, AJM editor-in-chief Dr. Joseph S. Alpert discusses this new research in the April 2017 issue of the American Journal of Medicine. Read the Research: […]

Read more
electrocardiogram print out with stethoscope

Silent Atrial Fibrillation and Cryptogenic Strokes

A new suspected cause of cryptic strokes is “silent atrial fibrillation.” Pacemakers and other implanted devices allow continuous recording of cardiac rhythm for months or years. They have discovered that short periods of atrial fibrillation lasting minutes or hours are frequent and usually are asymptomatic. A meta-analysis of 50 studies involving more than 10,000 patients […]

Read more

A Picture’s Worth: Giant Cell Arteritis

The ubiquitous smartphone became a helpful diagnostic tool when a patient used one to snap a photograph of her tongue. Although her symptoms were vague and nonspecific, her photograph facilitated the diagnosis of a serious, potentially debilitating illness. A generally healthy 63-year-old woman presented with a 1-week history of sore throat and periodic burning tongue […]

Read more

Triple vs Dual Antithrombotic Therapy in Patients with AF & CAD

Background The role of triple antithrombotic therapy vs dual antithrombotic therapy in patients with both atrial fibrillation and coronary artery disease remains unclear. This study explores the differences in treatment practices and outcomes between triple antithrombotic therapy and dual antithrombotic therapy in patients with atrial fibrillation and coronary artery disease. Methods Using the Outcomes Registry […]

Read more

National Trends in Ambulatory Oral Anticoagulant Use

A nationally representative audit of outpatient office visits shows that direct oral anticoagulants, associated with increased use of oral anticoagulation for patients with atrial fibrillation, are being rapidly adopted. Background Four direct oral anticoagulants (DOACs) have been brought to market for the treatment of nonvalvular atrial fibrillation and venous thromboembolism. Many forces, including numerous positive […]

Read more
UA-42320404-1